Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusAMP-activated protein kinase, stress responses and cardiovascular diseasesCardiovascular safety of anti-diabetic drugsCardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic MedicationsUse of metformin in diseases of agingDiabetic cardiomyopathy: bench to bedsideCongestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvementHeart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategiesShould antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress.The current role of thiazolidinediones in diabetes management.Diabetic cardiomyopathy: pathophysiology and clinical featuresOptimal therapy of type 2 diabetes: a controversial challengeMetformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2.AMPK activation--protean potential for boosting healthspan.Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of thiazolidinediones for diabetes.Heart failure in the diabetic population - pathophysiology, diagnosis and management.Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data.Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment.Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trialCardiovascular impact of drugs used in the treatment of diabetesClinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia.Glycyrrhizic acid can attenuate metabolic deviations caused by a high-sucrose diet without causing water retention in male Sprague-Dawley ratsMetformin use and mortality in ambulatory patients with diabetes and heart failure.Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulinPersonalizing guidelines for diabetes management: twilight or dawn of the expert?Cardiovascular safety profile of currently available diabetic drugs.Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks.AMP-activated protein kinase regulates E3 ligases in rodent heart.Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth MuscleMetformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trialTreatment of diabetes in the elderly. Addressing its complexities in this high-risk group.Recent findings concerning thiazolidinediones in the treatment of diabetes.
P2860
Q22241786-D68526E8-7EA4-46B7-9311-744E41223E3DQ24235718-B54A00F3-7390-4B4D-9563-D7902B290CC8Q24240522-8695AEA1-164F-4C72-B71D-7AE62ACB54BEQ24610297-845E5B31-372A-4776-96AF-A86421E834BDQ26741082-75E6909A-0916-497B-9EB1-7FBC5E72525BQ26824616-E3A45337-39AB-485C-9683-5FCB88C33621Q26828760-73763068-0BEE-42B6-81E4-6C6DBF2CE3DAQ26997062-4DDC9996-2746-458C-BBB3-2C2EA433E071Q27003819-B506F87E-2C17-4DEA-AD9F-3D6456F1BB1CQ27005955-CD8C0644-3136-40A4-A50E-D8370B7FD7C0Q27022813-96B6E257-49CD-4C5B-BA7A-0BEED76B6697Q28570993-8E4B822B-046C-45D3-8A46-CA197CD3A7D0Q30250347-AD16D56F-583A-402D-80F6-2DC065988AFBQ30457504-7684E1CA-049F-4308-9259-F4032DDD2798Q33577712-423A507F-5950-418D-A7F2-687AD00AC0E9Q33632353-C993552A-9823-42EF-9CEB-8A870DA554E3Q33689169-9F522604-831E-4402-AE15-0A5EAE677001Q33793434-D2BC3E00-5F04-4B21-AFFD-AFE8D1844F69Q33807810-5549A2D4-E6F3-4268-91F0-F4A0A375688AQ33935375-B9B81AD2-301B-4F75-9ACB-D62E5A484BF6Q34099031-F0948786-49D1-4D2F-8FFE-3DC0ECB61CB1Q34139048-EC25AD4D-998C-4A16-8E29-A55CF57D3430Q34248419-79D42C55-7AEF-41B5-9958-32592D6ED93DQ34383575-90AF6D08-8D74-4A00-9437-BFA6FA880DBBQ34410378-DDDB288E-2715-4A72-9F6D-272F2FDF3318Q34578006-292BD1DA-0C2A-490A-BFB8-131DF6146022Q34614524-8296DE0C-4696-48A7-87EA-B11C71BD097AQ34620604-B9C327A8-9407-4CAD-B26E-1B06B0092749Q34810165-43CC69EE-A957-4AD9-A2BB-CB8D7D88A13BQ34971736-1EEB63DE-B804-405D-9823-DBECF1566CB5Q35496697-3BBADA3E-380D-4471-BF8A-C6E8BD71414CQ35661532-BE80A035-1D34-4FBF-8741-F75D2DCE900BQ35973848-311EB620-8E22-4EA7-82C7-13F1DF3DD541Q35981002-13C48DB3-A7CC-43C3-A40B-415ED50ED22CQ36007665-E7868EF3-115B-485F-9D5F-FEB1B841B1D3Q36236500-A0D735CE-C65A-42AB-8CCD-278853EEA76AQ36240156-129A5DAB-0469-409B-8408-C5D5F8CA639AQ36297833-03054AF8-E1A1-4595-8876-86700044A2CFQ36331717-654BCC94-2A6E-4D0B-99B1-0030A6BABDDDQ36407304-7DD2CA03-EA41-4BB3-96B2-4AB7EDB521A0
P2860
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Thiazolidinediones, metformin, ...... ilure: an observational study.
@en
Thiazolidinediones, metformin, ...... ilure: an observational study.
@nl
type
label
Thiazolidinediones, metformin, ...... ilure: an observational study.
@en
Thiazolidinediones, metformin, ...... ilure: an observational study.
@nl
prefLabel
Thiazolidinediones, metformin, ...... ilure: an observational study.
@en
Thiazolidinediones, metformin, ...... ilure: an observational study.
@nl
P2093
P921
P1433
P1476
Thiazolidinediones, metformin, ...... ilure: an observational study.
@en
P2093
Edward P Havranek
JoAnne M Foody
Silvio E Inzucchi
Yongfei Wang
P304
P356
10.1161/01.CIR.0000154542.13412.B1
P407
P577
2005-02-01T00:00:00Z